OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs

Stocks TradingView By TradingView 28 Sep 2026 17:15 1 min read
OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs

OCUL Stock Suffers Sharpest Drop Since February As KOD And FDMT Post Updates On Their Wet AMD Drugs  TradingView

Covered in this story

Call it yourself

No calls on $OCUL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Ocular Therapeutix Inc →
Read the full story on TradingView → Opens the original article on news.google.com

Summary aggregated from TradingView's public RSS feed. The full reporting belongs to TradingView — please read it on their site.